z-logo
open-access-imgOpen Access
SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study
Author(s) -
F. Maurice,
PierresYves Ancel,
E. Mayoux,
I. Abdesselam,
Frank Kober,
P. Darmon,
M. Grino,
Bénédicte Gaborit,
Monique Bernard,
Anne Dutour
Publication year - 2017
Publication title -
hal (le centre pour la communication scientifique directe)
Language(s) - English
Resource type - Conference proceedings
Subject(s) - empagliflozin , ketone bodies , index (typography) , medicine , chemistry , cardiology , computer science , endocrinology , metabolism , type 2 diabetes , diabetes mellitus , world wide web

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom